Antimicrobial Stewardship: Optimization of Antibiotic Practices

Go to class
Write Review

Free Online Course: Antimicrobial Stewardship: Optimization of Antibiotic Practices provided by Coursera is a comprehensive online course, which lasts for 1-2 hours a week. The course is taught in English and is free of charge. Upon completion of the course, you can receive an e-certificate from Coursera. Antimicrobial Stewardship: Optimization of Antibiotic Practices is taught by Stan Deresinski.

Overview

  • Presented by:

      The Division of Infectious Diseases in the Department of Medicine at Stanford University School of Medicine

     >>>> NEWS FLASH ! <<<

    This course is now OPEN for ENROLLMENT
    at:

    https://med.stanford.edu/cme/courses/online/antimicrobial.html


    Dates & Durations:
    • Ongoing registration for this self-paced course is available until
      November 22nd , 2015
    • Estimated Time to Complete: Six hours
    • CME Processing Fee: $20
    • CME Credits Offered: 6.0

    To Obtain CME Credits*:
    • Review the information below, then click the Join for Free button to register and access the course material. If you have already registered for this activity, click the Go to Course button.
    • View all of the videos, then follow the link at the end of the last video to register for CME and pay the $20 CME Processing Fee.
    • Complete the CME course evaluation, CME post-assessment and CME post-test.
    • 75% of case-based post-test questions must be answered correctly in order to receive a CME certificate that will be emailed to the address provided within 2 weeks from the date of receipt.
    • Learners will have 3 attempts to pass the post-test.
    • The Stanford University School of Medicine designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    • *Participation in discussion forums, chat rooms, homework assignments and additional readings are not certified for AMA PRA Category 1 Credit™.

    Intended Audience
    This course will offer a practical approach to prescribing antibiotic therapy and development of antimicrobial stewardship to physicians and pharmacists across all specialties and settings.

    Course Description
    Antibiotics are among the most frequently prescribed classes of drugs and it is estimated that approximately 50% of antibiotic use, in both the outpatient and inpatient settings, is inappropriate. At the same time, in contrast to any other class of drugs, every antibiotic use has a potential public health consequence – inappropriate use may not harm only the individual patient, but contributes to societal harm by exerting an unnecessary selective pressure that may lead to antibiotic resistance among bacteria. This course will offer a number of illustrative cases, recognizable to the practicing physician in his or her practice to engage the learners in the thought processes that lead to optimal decision making, improved outcomes of individual patients, and harm reduction vis-a-vis the bacterial ecology.

    Learning Objectives
    • Develop skills to apply IDSA guidelines in treating common infections such as acute rhino-sinusitis.
    • Apply evidence based antibiotic management to treat sepsis.
    • Implement principles of antimicrobial stewardship when providing care to special populations and in various settings.
    • Apply evidence based antibiotic management to surgical patients requiring antibiotic prophylaxis.
    • Apply evidence based antibiotic stewardship program in the outpatient setting.
    Accreditation Statement
    The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement
    The Stanford University School of Medicine designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Disclosures
    The following Course Director has indicated that he has a relationship with industry to disclose relative to the content of this activity during the planning phase. This relationship no longer exists and as a faculty member he has nothing to disclose:
    Stan Deresinski, MD FIDSA
    Pfizer: Advisory Board member
    Clinical Professor, Medicine
    Infectious Disease
    Antimicrobial Stewardship Program Medical Director 
    Stanford University


    The following speakers have indicated that they have a relationship with industry to disclose relative to the content of this activity:
    Thomas File, Jr MD MACP FIDSA FCCP
    Professor of Internal Medicine
    Head ID Section
    Northeastern Ohio Universities Colleges of Medicine and Pharmacy
    Rootstown, Ohio
    Chief, Infectious Disease Service
    Summa Health System Akron, Ohio

    Astellas Pharma, Cubust, Durata, GSK, Merck: Advisory Board member
    Pfizer, Boehringer Ingelheim, Gilead, Tobotec: Research
    Bayer AG, DalishSankyo, Forest: Consulting


    Jason Newland, MD
    Medical Director, Patient Safety and System Reliability; Associate Professor of Pediatrics,
    University of Missouri-Kansas City School of Medicine
    Children’s Mercy Hospital Kansas City

    Pfizer: Research

    The following planners, speakers and authors have indicated that they have no relationships with industry to disclose relative to the content of this activity 
    Stan Deresinski, MD FIDSA
    Clinical Professor, Medicine
    Infectious Disease
    Antimicrobial Stewardship Program Medical Director
    Stanford University
    Speaker

    Lucy Tompkins, MD PhD FIDSA
    Hospital Epidemiologist
    Infectious Disease
    Co-Course Director, Content Reviewer, and Speaker

    Elizabeth Robilotti, MD MPH
    Instructor, Infectious Diseases
    Antimicrobial Stewardship Program 
    Principal Planner and Speaker

    Emily Mui, PharmD, BCPS
    Infectious Disease Pharmacist
    Antimicrobial Stewardship Program
    Stanford University
    Planner

    Niaz Banaei MD
    Assistant Professor of Pathology and Medicine (Infectious Diseases)
    Director, Clinical Microbiology Laboratory
    Speaker

    Anne Liu MD
    Clinical Assistant Professor, Pediatrics - Immunology and Allergy
    Clinical Assistant Professor, Medicine - Infectious Diseases
    Pediatric Allergy & Immunology Clinic
    Speaker

    Kavita Trivedi MD
    Public Health Medical Officer
    Healthcare Associated Infections Program
    Center for Health Care Quality
    California Department of Public Health
    Collaborator and Speaker

    Sasha Madison, MPH 
    Manager, Infection Prevention and Control Department 
    Stanford Hospital and Clinics
    Speaker 

    R. Michael Buckley, M.D.
    Executive Director
    Pennsylvania Hospital
    Professor of Clinical Medicine
    Perelman School of Medicine
    University of Pennsylvania
    Speaker

    Conan MacDougall, PharmD, MAS, BCPS
    Associate Professor of Clinical Pharmacy
    University of California San Francisco School of Pharmacy
    Speaker

    Kristi Kuper, PharmD, BCPS
    GSPC Clinical Pharmacy Manager
    VHA Performance Services
    Speaker

    Preeti N. Malani, MD, MSJ
    Associate Professor of Internal Medicine
    Divisions of Infectious Diseases and Geriatric and Palliative Medicine
    University of Michigan Medical School
    Veterans Affairs Ann Arbor Healthcare System
    Speaker

    Technical Design and Development
    Mike McAuliffe
    Stanford EdTech 
    Pauline Becker
    Stanford EdTech 
    Relly Brandman
    Coursera


    Contact Information
    For further information regarding the content, CME credit or if you experience any technical difficulties with this enduring material please send an email to [email protected]

    Commercial Support Acknowledgement
    Stanford University School of Medicine has received and has used undesignated program funding from Pfizer, Inc. to facilitate the development of innovative CME activities designed to enhance physician competence and performance and to implement advanced technology. A portion of this funding supports this activity.

    California Assembly Bill 1195 – Cultural and Linguistic Competency
    California Assembly Bill 1195 requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. It is the intent of the bill, which went into effect July 1, 2006, to encourage physicians and surgeons, CME providers in the State of California and the Accreditation Council for Continuing Medical Education to meet the cultural and linguistic concerns of a diverse patient population through appropriate professional development. The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area. The Stanford University School of Medicine Multicultural Health Portal also contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws. You are encouraged to visit the portal: lane.stanford.edu/portals/cultural.html


    Privacy
    cme.stanford.edu/policies/privacy.html


    Terms of Use
    www.stanford.edu/site/terms


Syllabus
  • Unit 1: The Basic Clinical Science of Antimicrobial Use:


      • Introduction to Antimicrobial Stewardship
      • The Story of Penicillin
      • Principles of Antimicrobial Use
      • Principles of Antibacterial Pharmacokinetics & Pharmacodynamics
      • Sepsis Case Study: Application of Principles
      • Introduction to Bacterial Resistance
      • Antibiotic Resistance: Gram Positive Resistance Beyond PCN
      • Antimicrobial Resistance: Mycobacterial, Viral and Fungal Resistant 
      • Acute Bacterial Skin and Skin Structure Infections
      • Antibiotic Allergies
      • Cystitis
      • Upper Respiratory Tract Infections
      • Community Acquired Pneumonia in the Outpatient Setting

    Unit 2: Practical Aspects of Antimicrobial Stewardship and Application to Special Circumstances and Populations:

      • Antibiotic Stewardship Interventions
      • Convincing the C-Suite
      • Measurements and Metrics
      • Incorporating Clinical Decision Support into Stewardship
      • Diagnostics 
      • Infection Prevention and Antimicrobial Stewardship
      • Surgical Site Prophylaxis 
      • Out-Patient Parenteral Therapy
      • Antimicrobial Stewardship in Pediatrics 
      • Antimicrobial Stewardship and Transplant Infectious Diseases
      • Antimicrobial Stewardship: Long-term Care
      • Antimicrobial Use at the end of life
      • Conclusion

Tags